Inmune Bio, Inc.
INMBNasdaqCIK 1711754HealthcareFiscal year ends Dec 31
All transactions: 4
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2021-09-03 | Xencor Inc10% owner | Option exercise | 108,000 | $7.80 | $842.4k | Form 4 |
| 2021-06-10 | Xencor Inc10% owner | Other | 192,532 | $17.14 | $3.3m | Form 4 |
| 2021-06-10 | Xencor Inc10% owner | Other | 192,533 | $17.14 | $3.3m | Form 4/A |
| 2021-06-10 | Xencor Inc10% owner | Other | 192,533 | $17.14 | $3.3m | Form 4/A |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 29, 2026, 07:41 ET. Listed shows no prices and gives no investment advice.